Effects of curcumin to counteract levodopa-induced toxicity in zebrafish

References

• Abrao, L. C., D. G. Costa-Silva, M. G. Santos, M. B. R. Cerqueira, E. Badiale-Furlong, A. L. Muccillo-Baisch, and M. A. Hort. 2022. Toxicity evaluation of traditional and organic yerba mate (Ilex paraguariensis A. St.-Hil.) extracts. J. Toxicol. Environ. Health A 85 (11):461–79. doi:10.1080/15287394.2022.2035873.
   PubMed Web of Science ®Google Scholar
• Agostini, J. F., G. D. Santo, S. L. Baldin, H. T. Bernardo, A. C. S. de Farias, E. P. Rico, and A. G. Wanderley. 2021. Gallic acid reverses neurochemical changes induced by prolonged ethanol exposure in the zebrafish brain. Neuroscience 455:251–62. doi:10.1016/j.neuroscience.2020.11.040.
   PubMed Web of Science ®Google Scholar
• Aleström, P., L. D’Angelo, P. J. Midtlyng, D. F. Schorderet, S. Schulte-Merker, F. Sohm, and S. Warner. 2020. Zebrafish: housing and husbandry recommendations. Lab. Anim. 54 (3):213–24. doi:10.1177/0023677219869037.
   PubMed Web of Science ®Google Scholar
• Altenhofen, S., D. D. Nabinger, P. E. R. Bitencourt, and C. D. Bonan. 2019. Dichlorvos alters morphology and behavior in zebrafish (Danio rerio) larvae. Environ. Pollut. 245:1117–23. doi:10.1016/j.envpol.2018.11.095.
   PubMed Web of Science ®Google Scholar
• Antonini, A., E. Tolosa, Y. Mizuno, M. Yamamoto, and W. H. Poewe. 2009. A reassessment of risks and benefits of dopamine agonists in Parkinson’s disease. Lancet Neurol. 8 (10):929–37. doi:10.1016/S1474-4422(09)70225-X.
   PubMed Web of Science ®Google Scholar
• Atzei, A., I. Jense, E. P. Zwart, J. Legradi, B. J. Venhuis, L. T. M. van der Ven, H. J. Heusinkveld, and E. V. S. Hessel. 2021. Developmental neurotoxicity of environmentally relevant pharmaceuticals and mixtures thereof in a zebrafish embryo behavioural test. Int. J. Env. Res. Pub. He. 18 (13):6717–19. doi:10.3390/ijerph18136717.
   PubMed Web of Science ®Google Scholar
• Bagheri, H., F. Ghasemi, G. E. Barreto, R. Rafiee, T. Sathyapalan, and A. Sahebkar. 2020. Effects of curcumin on mitochondria in neurodegenerative diseases. BioFactors 46 (1):5–20. doi:10.1002/biof.1566.
   PubMed Web of Science ®Google Scholar
• Balestrino, R., and A. H. V. Schapira. 2020. Parkinson disease. Eur. J. Neurol. 27 (1):27–42. doi:10.1111/ene.14108.
   PubMed Web of Science ®Google Scholar
• Bao, W., A. D. Volgin, E. T. Alpyshov, A. J. Friend, T. V. Strekalova, M. S. de Abreu, C. Collins, T. G. Amstislavskaya, K. A. Demin, and A. V. Kalueff. 2019. Opioid neurobiology, neurogenetics and neuropharmacology in zebrafish. Neuroscience 404:218–32. doi:10.1016/j.neuroscience.2019.01.045.
   PubMed Web of Science ®Google Scholar
• Barclay, L. R. C., M. R. Vinqvist, K. Mukai, H. Goto, Y. Hashimoto, A. Tokunaga, and H. Uno. 2000. On the antioxidant mechanism of curcumin: classical methods are needed to determine antioxidant mechanism and activity. Org. Lett. 2 (18):2841–43. doi:10.1021/ol000173t.
   PubMed Web of Science ®Google Scholar
• Barros, S., A. M. Coimbra, N. Alves, M. Pinheiro, J. B. Quintana, M. M. Santos, and T. Neuparth. 2020. Chronic exposure to environmentally relevant levels of simvastatin disrupts zebrafish brain gene signaling involved in energy metabolism. J. Toxicol. Environ. Health A 83 (3):113–25. doi:10.1080/15287394.2020.1733722.
   PubMed Web of Science ®Google Scholar
• Basnet, R. M., D. Zizioli, S. Taweedet, D. Finazzi, and M. Memo. 2019. Zebrafish larvae as a behavioral model in neuropharmacology. Biomedicines 7 (1):23. doi:10.3390/biomedicines7010023.
   PubMed Web of Science ®Google Scholar
• Benameur, T., G. Giacomucci, M. A. Panaro, M. Ruggiero, T. Trotta, V. Monda, I. Pizzolorusso, D. D. Lofrumento, C. Porro, and G. Messina. 2021. New promising therapeutic avenues of curcumin in brain diseases. Molecules 27 (1):236. doi:10.3390/molecules27010236.
   PubMed Web of Science ®Google Scholar
• Bradford, M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1–2):248–54. doi:10.1016/0003-2697(76)90527-3.
   PubMed Web of Science ®Google Scholar
• Briñez-Gallego, P., D. G. da Costa Silva, M. F. Cordeiro, A. P. Horn, and M. A. Hort. 2023. Experimental models of chemically induced Parkinson’s disease in zebrafish at the embryonic larval stage: a systematic review. J. Toxicol. Environ. Health - B. 26 (4):201–37. doi:10.1080/10937404.2023.2182390.
   PubMed Web of Science ®Google Scholar
• Brustein, E., L. Saint-Amant, R. R. Buss, M. Chong, J. R. McDearmid, and P. Drapeau. 2003. Steps during the development of the zebrafish locomotor network. J. Physiol. (Paris) 97 (1):77–86. doi:10.1016/j.jphysparis.2003.10.009.
   PubMedGoogle Scholar
• Burgess, H. A., and M. Granato. 2007. Modulation of locomotor activity in larval zebrafish during light adaptation. J. Exp. Biol. 210 (14):2526–39. doi:10.1242/jeb.003939.
   PubMed Web of Science ®Google Scholar
• Cassar, S., I. Adatto, J. L. Freeman, J. T. Gamse, I. Iturria, C. Lawrence, A. Muriana, R. T. Peterson, S. Van Cruchten, and L. I. Zon. 2020. Use of zebrafish in drug discovery toxicology. Chem. Res. Toxicol. 33 (1):95–118. doi:10.1021/acs.chemrestox.9b00335.
   PubMed Web of Science ®Google Scholar
• Cheng, R. K., S. Krishnan, and S. Jesuthasan. 2016. Activation and inhibition of tph2 serotonergic neurons operate in tandem to influence larval zebrafish preference for light over darkness. Sci. Rep. 6 (1):1–10. doi:10.1038/srep20788.
   PubMedGoogle Scholar
• Chen, Z., G. Li, and J. Liu. 2020. Autonomic dysfunction in Parkinson’s disease: Implications for pathophysiology, diagnosis, and treatment. Neurobiol. Dis. 134:104700. doi:10.1016/j.nbd.2019.104700.
   PubMed Web of Science ®Google Scholar
• Colón-Cruz, L., L. Kristofco, J. Crooke-Rosado, A. Acevedo, A. Torrado, B. W. Brooks, M. A. Sosa, and M. Behra. 2018. Alterations of larval photo-dependent swimming responses (pdr): New endpoints for rapid and diagnostic screening of aquatic contamination. Ecotox. Environ. Safe. 147:670–80. doi:10.1016/j.ecoenv.2017.09.018.
   PubMed Web of Science ®Google Scholar
• Concea. 2018. Resolução Normativa No 37, de 15 de Fevereiro de 2018. Brasília. Conselho Nacional de Controle de Experimentação Animal. Diretriz Da Prática de Eutanásia: 49.
   Google Scholar
• Concetta Scuto, M., C. Mancuso, B. Tomasello, M. Laura Ontario, A. Cavallaro, F. Frasca, L. Maiolino, A. Trovato Salinaro, E. J. Calabrese, and V. Calabrese. 2019. Curcumin, hormesis and the nervous system. Nutrients 11 (10):2417. doi:10.3390/nu11102417.
   PubMed Web of Science ®Google Scholar
• Costa-Silva, D. G., L. P. Leandro, P. B. Vieira, N. R. de Carvalho, A. R. Lopes, L. E. Schimith, M. E. M. Nunes, R. S. de Mello, I. K. Martins, A. A. de Paula, et al. 2018. N-acetylcysteine inhibits mancozeb-induced impairments to the normal development of zebrafish embryos. Neurotoxicol. Teratol. 68:1–12. doi:10.1016/j.ntt.2018.04.003.
   PubMed Web of Science ®Google Scholar
• Crilly, S., A. Parry-Jones, X. Wang, J. N. Selley, J. Cook, V. S. Tapia, C. S. Anderson, S. M. Allan, and P. R. Kasher. 2022. Zebrafish drug screening identifies candidate therapies for neuroprotection after spontaneous intracerebral haemorrhage. Dis. Model Mech. 15 (3):dmm049227. doi:10.1242/dmm.049227.
   PubMed Web of Science ®Google Scholar
• Dominiak, K., and W. Jarmuszkiewicz. 2021. The relationship between mitochondrial reactive oxygen species production and mitochondrial energetics in rat tissues with different contents of reduced coenzyme Q. Antioxidants 10 (4):533. doi:10.3390/antiox10040533.
   Web of Science ®Google Scholar
• Doyle, J. M., and R. P. Croll. 2022. A critical review of zebrafish models of Parkinson’s disease. Front Pharmacol. 13:835827. doi:10.3389/fphar.2022.835827.
   PubMed Web of Science ®Google Scholar
• Drapeau, P., L. Saint-Amant, R. R. Buss, M. Chong, J. R. McDearmid, and E. Brustein. 2002. Development of the locomotor network in zebrafish. Prog. Neurobiol. 68 (2):85–111. doi:10.1016/S0301-0082(02)00075-8.
   PubMed Web of Science ®Google Scholar
• Esterbauer, H., and K. H. Cheeseman. 1990. Determination of aldehydic lipid peroxidation products: Malonaldehyde and 4-hydroxynonenal. Methods Enzymol. 186:407–21.
   PubMed Web of Science ®Google Scholar
• Farrell, T. C., C. L. Cario, C. Milanese, A. Vogt, J. H. Jeong, and E. A. Burton. 2011. Evaluation of spontaneous propulsive movement as a screening tool to detect rescue of parkinsonism phenotypes in zebrafish models. Neurobiol. Dis. 44 (1):9–18. doi:10.1016/j.nbd.2011.05.016.
   PubMed Web of Science ®Google Scholar
• Félix, L. M., A. Luzio, A. Santos, L. M. Antunes, A. M. Coimbra, and A. M. Valentim. 2020. MS-222 induces biochemical and transcriptional changes related to oxidative stress, cell proliferation and apoptosis in zebrafish embryos. Comp. Biochem. Physiol. Part C: Toxicol. Pharmacol. 237:108834. doi:10.1016/j.cbpc.2020.108834.
   PubMed Web of Science ®Google Scholar
• Fontana, B. D., N. J. Mezzomo, A. V. Kalueff, and D. B. Rosemberg. 2018. The developing utility of zebrafish models of neurological and neuropsychiatric disorders: A critical review. Exp. Neurol. 299:157–71. doi:10.1016/j.expneurol.2017.10.004.
   PubMed Web of Science ®Google Scholar
• Francardo, V., and M. A. Cenci. 2014. Investigating the molecular mechanisms of L-DOPA-induced dyskinesia in the mouse. Parkinsonism Relat. Disord. 20:S20–S22. doi:10.1016/S1353-8020(13)70008-7.
   PubMedGoogle Scholar
• Gao, X. P., F. Feng, X. Q. Zhang, X. X. Liu, Y. B. Wang, J. X. She, Z. H. He, and M. F. He. 2014. Toxicity assessment of 7 anticancer compounds in zebrafish. 2014. Int. J. Toxicol. 33 (2):98–105. doi:10.1177/1091581814523142.
   PubMed Web of Science ®Google Scholar
• Genario, R., M. S. de Abreu, A. C. V. V. Giacomini, K. A. Demin, and A. V. Kalueff. 2020. Sex differences in behavior and neuropharmacology of zebrafish. Eur. J. Neurosci. 52 (1):2586–603. doi:10.1111/ejn.14438.
   PubMed Web of Science ®Google Scholar
• Haney, W. A., B. Moussaoui, and J. A. Strother. 2020. Prolonged exposure to stressors suppresses exploratory behavior in zebrafish larvae. J. Exp. Biol. 223:jeb224964. doi:10.1242/jeb.224964.
   PubMed Web of Science ®Google Scholar
• Hansen, C. A., D. R. Miller, S. Annarumma, C. T. Rusch, A. Ramirez-Zamora, and H. Khoshbouei. 2022. Levodopa-induced dyskinesia: a historical review of Parkinson’s disease, dopamine, and modern advancements in research and treatment. J. Neurol. 269 (6):2892–909. doi:10.1007/s00415-022-10963-w.
   PubMed Web of Science ®Google Scholar
• Hauser, R. A. 2009. Levodopa: past, present, and future. Eur. Neurol. 62 (1):1–8. doi:10.1159/000215875.
   PubMed Web of Science ®Google Scholar
• Havermans, A., E. P. Zwart, H. W. J. M. Cremers, M. D. M. van Schijndel, R. S. Constant, M. Mešković, L. X. Worutowicz, J. L. A. Pennings, R. Talhout, L. T. M. van der Ven, et al. 2021. Exploring neurobehaviour in zebrafish embryos as a screening model for addictiveness of substances. Toxics. 9(10):250. doi:10.3390/toxics9100250.
   PubMed Web of Science ®Google Scholar
• Hernandez, R. E., L. Galitan, J. Cameron, N. Goodwin, and L. Ramakrishnan. 2018. Delay of initial feeding of zebrafish larvae until 8 days postfertilization has no impact on survival or growth through the juvenile stage. Zebrafish 15 (5):515–18. doi:10.1089/zeb.2018.1579.
   PubMed Web of Science ®Google Scholar
• He, H.-J., X. Xiong, S. Zhou, X.-R. Zhang, X. Zhao, L. Chen, and C.-L. Xie. 2022. Neuroprotective effects of curcumin via autophagy induction in 6-hydroxydopamine Parkinson’s models. Neurochem. Int. 155:105297. doi:10.1016/j.neuint.2022.105297.
   PubMed Web of Science ®Google Scholar
• Idalencio, R., T. M. Lopes, S. M. Soares, A. Pompermaier, B. de Alcantara, H. H. Kalichak, F. Fagundes, C. M. de Oliveira, and L. J. Barcellos. 2021. Effect of levodopa/carbidopa on stress response in zebrafish. J. Comp. Physiol. A. doi:10.1007/s00359-021-01479-1.
   Web of Science ®Google Scholar
• Igartua, D. E., C. S. Martinez, S. V. Alonso, N. S. Chiaramoni, and M. J. Prieto. 2020. Toxicity assessment of free and dendrimer-complexed curcumin in zebrafish larvae. Pharmanutrition 13:100201. doi:10.1016/j.phanu.2020.100201.
   Web of Science ®Google Scholar
• Irons, T. D., R. C. MacPhail, D. L. Hunter, and S. Padilla. 2010. Acute neuroactive drug exposures alter locomotor activity in larval zebrafish. Neurotoxicol. Teratol. 32 (1):84–90. doi:10.1016/j.ntt.2009.04.066.
   PubMed Web of Science ®Google Scholar
• Jagatha, B., R. B. Mythri, S. Vali, and M. M. S. Bharath. 2008. Curcumin treatment alleviates the effects of glutathione depletion in vitro and in vivo: therapeutic implications for Parkinson’s disease explained via in silico studies. Free Radic. Biol. Med. 44 (5):907–17. doi:10.1016/j.freeradbiomed.2007.11.011.
   PubMed Web of Science ®Google Scholar
• Kalia, L. V., and A. E. Lang. 2015. Parkinson’s disease. The Lancet 386:896–912. doi:10.1016/S0140-6736(14)61393-3. 9996
   PubMed Web of Science ®Google Scholar
• Kalueff, A. V., A. M. Stewart, and R. Gerlai. 2014. Zebrafish as an emerging model for studying complex brain disorders. Trends Pharmacol. Sci. 35 (2):63–75. doi:10.1016/j.tips.2013.12.002.
   PubMed Web of Science ®Google Scholar
• Khan, K. M., A. D. Collier, D. A. Meshalkina, E. V. Kysil, S. L. Khatsko, T. Kolesnikova, Y. Y. Morzherin, J. E. Warnick, A. V. Kalueff, and D. J. Echevarria. 2017. Zebrafish models in neuropsychopharmacology and CNS drug discovery. Br. J. Pharmacol. 174 (13):1925–44. doi:10.1111/bph.13754.
   PubMed Web of Science ®Google Scholar
• Kotha, T. R., and D. Luthria. 2019. Curcumin: biological, pharmaceutical, nutraceutical, and analytical aspects. Molecules 24 (16):2930. doi:10.3390/molecules24162930.
   PubMed Web of Science ®Google Scholar
• Kulkarni, S. K., M. K. Bhutani, and M. Bishnoi. 2008. Antidepressant activity of curcumin: involvement of serotonin and dopamine system. Psychopharmacology 201 (3):435–42. doi:10.1007/s00213-008-1300-y.
   PubMed Web of Science ®Google Scholar
• Li, Q., J. Lin, Y. Zhang, X. Liu, X. Q. Chen, M.-Q. Xu, L. He, S. Li, and N. Guo. 2015. Differential behavioral responses of zebrafish larvae to yohimbine treatment. Psychopharmacology 232:197–208. doi:10.1007/s00213-014-3656-5.
   PubMed Web of Science ®Google Scholar
• Lin, X., D. Bai, Z. Wei, Y. Zhang, Y. Huang, H. Deng, X. Huang, and P. Mukhopadhyay. 2019. Curcumin attenuates oxidative stress in RAW264.7 cells by increasing the activity of antioxidant enzymes and activating the Nrf2-Keap1 pathway. PLoS One 14 (5):e0216711. doi:10.1371/journal.pone.0216711.
   PubMed Web of Science ®Google Scholar
• Lipski, J., R. Nistico, N. Berretta, E. Guatteo, G. Bernardi, and N. B. Mercuri. 2011. L-DOPA: a scapegoat for accelerated neurodegeneration in Parkinson’s disease? Prog. Neurobiol. 94 (4):389–407. doi:10.1016/j.pneurobio.2011.06.005.
   PubMed Web of Science ®Google Scholar
• Liu, J., Y. Lu, M. Tang, F. Shao, D. Yang, S. Chen, Z. Xu, L. Zhai, J. Chen, Q. Li et al. 2022. Fucoxanthin prevents long-term administration l-DOPA-induced neurotoxicity through the erk/jnk-c-jun system in 6-OHDA-lesioned mice and PC12 cells. Mar Drugs. 20(4):245. doi:10.3390/md20040245.
   PubMed Web of Science ®Google Scholar
• Lockwood, B., S. Bjerke, K. Kobayashi, and S. Guo. 2004. Acute effects of alcohol on larval zebrafish: A genetic system for large-scale screening. Pharmacol. Biochem. Behav. 77 (3):647–54. doi:10.1016/j.pbb.2004.01.003.
   PubMed Web of Science ®Google Scholar
• Lohr, K. M., S. T. Masoud, A. Salahpour, G. W. Miller, and P. Bolam. 2017. Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease. Eur. J. Neurol. 45 (1):30–33. doi:10.1111/ejn.13357.
   Google Scholar
• MacRae, C. A., and R. T. Peterson. 2015. Zebrafish as tools for drug discovery. Nat. Rev. Drug Discov. 14 (10):721–31. doi:10.1038/nrd4627.
   PubMed Web of Science ®Google Scholar
• Malave, L., D. R. Zuelke, S. Uribe-Cano, L. Starikov, H. Rebholz, E. Friedman, C. Qin, Q. Li, E. Bezard, and A. H. Kottmann. 2021. Dopaminergic co-transmission with sonic hedgehog inhibits abnormal involuntary movements in models of Parkinson’s disease and l-DOPA induced dyskinesia. Commun. Biol. 4 (1):1–16. doi:10.1038/s42003-021-02567-3.
   PubMed Web of Science ®Google Scholar
• Marques, M. S., M. F. Cordeiro, M. A. G. Marinho, C. O. Vian, G. R. Vaz, B. S. Alves, R. D. Jardim, M. A. Hort, C. L. Dora, and A. P. Horn. 2020. Curcumin-loaded nanoemulsion improves haemorrhagic stroke recovery in wistar rats. Brain Res. 1746:147007. doi:10.1016/j.brainres.2020.147007.
   PubMed Web of Science ®Google Scholar
• Medeiros, M. S., A. F. Schumacher-Schuh, V. Altmann, and C. R. M. Rieder. 2021. A case-control study of the effects of chimarrão (Ilex paraguariensis) and coffee on Parkinson’s disease. Front Neurol. 12:1–6. doi:10.3389/fneur.2021.619535.
   Web of Science ®Google Scholar
• Mogharbel, B. F., M. A. Cardoso, A. C. Irioda, P. E. F. Stricker, R. C. Slompo, J. M. Appel, N. B. de Oliveira, M. C. Perussolo, C. S. Saçaki, N. N. da Rosa, et al. 2022. Biodegradable nanoparticles loaded with levodopa and curcumin for treatment of Parkinson’s disease. Molecules 27 (9):2811. doi:10.3390/molecules27092811.
   PubMed Web of Science ®Google Scholar
• Mugoni, V., A. Camporeale, and M. M. Santoro. 2014. Analysis of oxidative stress in zebrafish embryos. J. Vis. Exp. 89 (89):1–11. doi:10.3791/51328.
   Google Scholar
• Mythri, B. R., and M. Srinivas Bharath. 2012. Curcumin: a potential neuroprotective agent in Parkinson disease. Curr. Pharm. Des. 18 (1):91–99. doi:10.2174/138161212798918995.
   PubMed Web of Science ®Google Scholar
• Nebrisi, E. E. 2021. Neuroprotective activities of curcumin in Parkinson’s disease: A review of the literature. Int. J. Mol. Sci. 22 (20):11248. doi:10.3390/ijms222011248.
   PubMed Web of Science ®Google Scholar
• Nikolova, G., Y. Karamalakova, and V. Gadjeva. 2019. Reducing oxidative toxicity of l-dopa in combination with two different antioxidants: An essential oil isolated from Rosa damascena Mill., and vitamin C. Toxicol. Rep. 6:267–71. doi:10.1016/j.toxrep.2019.03.006.
   PubMed Web of Science ®Google Scholar
• Olanow, C. W. 2015. Levodopa: effect on cell death and the natural history of Parkinson’s disease. Mov. Disorders 30 (1):37–44. doi:10.1002/mds.26119.
   PubMed Web of Science ®Google Scholar
• Park, J. H., <. N.<. N. Lee, and H. S. Kim. 2021. Potential protective roles of curcumin against cadmium-induced toxicity and oxidative stress. J. Toxicol. Environ. Health - B. 24 (3):95–118. doi:10.1080/10937404.2020.1860842.
   PubMed Web of Science ®Google Scholar
• Pípal, M., J. Legradi, M. Smutná, T. Kočí, J. Priebojová, L. Bláhová, M. Krauss, and K. Hilscherová. 2020. Neurobehavioral effects of cyanobacterial biomass field extracts on zebrafish embryos and potential role of retinoids. Aquatic Toxicol. 228:105613. doi:10.1016/j.aquatox.2020.105613.
   PubMed Web of Science ®Google Scholar
• Poewe, W., and P. Mahlknecht. 2020. Pharmacologic treatment of motor symptoms associated with Parkinson disease. Neurol. Clin. 38 (2):255–67. doi:10.1016/j.ncl.2019.12.002.
   PubMed Web of Science ®Google Scholar
• Poewe, W., K. Seppi, C. M. Tanner, G. M. Halliday, P. Brundin, J. Volkmann, A.-E. Schrag, and A. E. Lang. 2017. Parkinson disease. Nat. Rev. Dis. Primers. 3 (1):17013. doi:10.1038/nrdp.2017.13.
   PubMed Web of Science ®Google Scholar
• Priyadarsini, K. I., D. K. Maity, G. H. Naik, M. S. Kumar, M. K. Unnikrishnan, J. G. Satav, and H. Mohan. 2003. Role of phenolic O-H and methylene hydrogen on the free radical reactions and antioxidant activity of curcumin. Free Radic. Biol. Med. 35 (5):475–84. doi:10.1016/S0891-5849(03)00325-3.
   PubMed Web of Science ®Google Scholar
• Pulido-Moran, M., J. Moreno-Fernandez, C. Ramirez-Tortosa, and M. Ramirez-Tortosa. 2016. Curcumin and health. Molecules 21 (3):264. doi:10.3390/molecules21030264.
   PubMed Web of Science ®Google Scholar
• Rakshi, J. S., N. Pavese, T. Uema, K. Ito, P. K. Morrish, D. L. Bailey, and D. J. Brooks. 2002. A comparison of the progression of early Parkinson’s disease in patients started on ropinirole or L-DOPA: An 18 F-DOPA PET study. J. Neural Transm. 109 (12):1433–43. doi:10.1007/s00702-002-0753-0.
   PubMed Web of Science ®Google Scholar
• Ramires Júnior, O. V., B. D. S. Alves, P. A. B. Barros, J. L. Rodrigues, S. P. Ferreira, L. K. S. Monteiro, G. D. M. S. Araújo, S. S. Fernandes, G. R. Vaz, C. L. Dora, et al. 2021. Nanoemulsion improves the neuroprotective effects of curcumin in an experimental model of Parkinson’s disease. Neurotox Res. 39(3):787–99. doi:10.1007/s12640-021-00362-w.
   PubMed Web of Science ®Google Scholar
• Reich, S. G., and J. M. Savitt. 2019. Parkinson’s disease. Med. Clin. North Am. 103 (2):337–50. doi:10.1016/j.mcna.2018.10.014.
   PubMed Web of Science ®Google Scholar
• Rink, E., and M. F. Wullimann. 2004. Connections of the ventral telencephalon (subpallium) in the zebrafish (Danio rerio). Brain Res. 1011 (2):206–20. doi:10.1016/j.brainres.2004.03.027.
   PubMed Web of Science ®Google Scholar
• Ryu, Y.-K., H.-Y. Park, J. Go, Y.-H. Kim, J. H. Hwang, D.-H. Choi, J.-R. Noh, M. Rhee, P.-L. Han, C.-H. Lee et al. 2018. Effects of histone acetyltransferase inhibitors on l-DOPA-induced dyskinesia in a murine model of Parkinson’s disease. J. Neural. Transm. 125(9):1319–31. doi:10.1007/s00702-018-1902-4.
   PubMed Web of Science ®Google Scholar
• Sachett, A., R. Benvenutti, C. G. Reis, M. Gallas-Lopes, L. M. Bastos, G. P. S. Aguiar, A. P. Herrmann, J. V. Oliveira, A. M. Siebel, and A. Piato. 2022. Micronized curcumin causes hyperlocomotion in zebrafish larvae. Neurochem. Res. 47 (2316): 2307.
   PubMedGoogle Scholar
• Sachett, A., F. Bevilaqua, R. Chitolina, C. Garbinato, H. Gasparetto, J. Dal Magro, G. M. Conterato, and A. M. Siebel. 2018. Ractopamine hydrochloride induces behavioral alterations and oxidative status imbalance in zebrafish. 2018. J. Toxicol. Environ. Health A 81 (7):194–201. doi:10.1080/15287394.2018.1434848.
   PubMed Web of Science ®Google Scholar
• Shah, M., W. Murad, S. Mubin, O. Ullah, N. U. Rehman, and M. H. Rahman. 2022. Multiple health benefits of curcumin and its therapeutic potential. Environ. Sci. Pollut. Res. 29 (29):43732–44. doi:10.1007/s11356-022-20137-w.
   PubMed Web of Science ®Google Scholar
• Shehata, A. M., O. A. Ahmed-Farid, H. A. Rizk, S. M. Saber, F. M. Lashin, and L. Re. 2020. Neurochemical, neurobehavioral and histochemical effects of therapeutic dose of L-DOPA on striatal neurons in rats: protective effect of virgin coconut oil. Biomed. Pharmacother. 130:110473. doi:10.1016/j.biopha.2020.110473.
   PubMed Web of Science ®Google Scholar
• Simon, D. K., and C. M. Tanner and P. P. Brundin. 2020. Parkinson disease epidemiology, pathology, genetics, and pathophysiology. Clin. Geriatr. Med. 36 (1):1–12. doi:10.1016/j.cger.2019.08.002.
   PubMed Web of Science ®Google Scholar
• Smith, T. S., W. D. Parker, and J. P. Bennett. 1994. L-dopa increases nigral production of hydroxyl radicals in vivo: potential L-DOPA toxicity? Neuroreport 5 (8):1009–11. doi:10.1097/00001756-199404000-00039.
   PubMed Web of Science ®Google Scholar
• Stednitz, S. J., B. Freshner, S. Shelton, T. Shen, D. Black, and E. Gahtan. 2015. Selective toxicity of l-DOPA to dopamine transporter-expressing neurons and locomotor behavior in zebrafish larvae. Neurotoxicol. Teratol. 52:51–56. doi:10.1016/j.ntt.2015.11.001.
   PubMed Web of Science ®Google Scholar
• Vaccari, C. R., El Dib, H. Gomaa, L. C. Lopes, J. L. de Camargo, and R. El Dib. 2019. Paraquat and Parkinson’s disease: A systematic review and meta-analysis of observational studies. J. Toxicol. Environ. Health - B. 22 (5–6):172–202. doi:10.1080/10937404.2019.1659197.
   PubMed Web of Science ®Google Scholar
• Vaz, R. L., T. F. Outeiro, and J. J. Ferreira. 2018. Zebrafish as an animal model for drug discovery in Parkinson’s disease and other movement disorders: A systematic review. Front Neurol. 9:347. doi:10.3389/fneur.2018.00347.
   PubMed Web of Science ®Google Scholar
• Victoria, S., M. Hein, E. Harrahy, and T. C. King-Heiden. 2022. Potency matters: Impacts of embryonic exposure to nAchr agonists thiamethoxam and nicotine on hatching success, growth, and neurobehavior in larval zebrafish. 2022. J. Toxicol. Environ. Health A 85 (18):767–82. doi:10.1080/15287394.2022.2081641.
   PubMed Web of Science ®Google Scholar
• Wang, Y. L., B. Ju, Y. Z. Zhang, H. L. Yin, Y. J. Liu, S. S. Wang, Z. L. Zeng, X. P. Yang, H. T. Wang, and J. F. Li. 2017. Protective effect of curcumin against oxidative stress-induced injury in rats with Parkinson’s disease through the wnt/β-catenin signaling pathway. Cell. Physiol. Biochem. 43 (6):2226–41. doi:10.1159/000484302.
   PubMedGoogle Scholar
• Wang, X.-S., Z.-R. Zhang, M.-M. Zhang, M.-X. Sun, W.-W. Wang, and C.-L. Xie. 2017. Neuroprotective properties of curcumin in toxin-base animal models of Parkinson’s disease: A systematic experiment literatures review. BMC Complement Altern. Med. 17 (1):412. doi:10.1186/s12906-017-1922-x.
   PubMed Web of Science ®Google Scholar
• Westerfield, M. 2007. The zebrafish book. A guide for the laboratory use of zebrafish (Danio Rerio). 5th ed. Eugene (Book): University of Oregon Press.
   Google Scholar
• Wu, J. Y., C. Y. Lin, T. W. Lin, C. F. Ken, and Y. Der Wen. 2007. Curcumin affects development of zebrafish embryo. Biol. Pharm. Bull. 30 (7):1336–39. doi:10.1248/bpb.30.1336.
   PubMed Web of Science ®Google Scholar
• Xi, Y., S. Noble, and M. Ekker. 2011. Modeling neurodegeneration in zebrafish. Curr. Neurol. Neurosci. Rep. 11 (3):274–82. doi:10.1007/s11910-011-0182-2.
   PubMed Web of Science ®Google Scholar
• Xi, Y., M. Yu, R. Godoy, G. Hatch, L. Poitras, and M. Ekker. 2011. Transgenic zebrafish expressing green fluorescent protein in dopaminergic neurons of the ventral diencephalon. Dev. Dynam. 240 (11):2539–47. doi:10.1002/dvdy.22742.
   PubMed Web of Science ®Google Scholar
• Xu, Y., B.-S. Ku, H.-Y. Yao, Y.-H. Lin, X. Ma, Y.-H. Zhang, and X.-J. Li. 2005. The effects of curcumin on depressive-like behaviors in mice. Eur. J. Pharmacol. 518 (1):40–46. doi:10.1016/j.ejphar.2005.06.002.
   PubMed Web of Science ®Google Scholar
• Zhang, S., R. Wang, and G. Wang. 2019. Impact of dopamine oxidation on dopaminergic neurodegeneration. ACS Chem. Neurosci. 10 (2):945–53. doi:10.1021/acschemneuro.8b00454.
   PubMed Web of Science ®Google Scholar